Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.880
-0.070 (-3.59%)
Jan 21, 2025, 4:00 PM EST - Market closed
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $126.38 million as of January 22, 2025. Its market cap has increased by 67.90% in one year.
Market Cap
126.38M
Enterprise Value
-91.49M
1-Year Change
67.90%
Ranking
Category
Stock Price
1.88
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $126.38M, a decrease of -68.66%. That is a compound annual growth rate of -28.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 131.09M | 8.33% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 668.44B |
| UnitedHealth Group | 483.14B |
| Johnson & Johnson | 356.69B |
| Novo Nordisk | 355.58B |
| AbbVie | 305.03B |
| Merck & Co. | 243.45B |
| Thermo Fisher Scientific | 219.20B |
| Intuitive Surgical | 215.18B |